Investment
Features
FeesSafety
Academy
More
Pluang+

VisionWave develops Stratum AI to coordinate autonomous defense and security systems with real-time decision support.

Market News
14 Oct 2026
GlobeNewsWire
View Source
Neutral
VisionWave develops Stratum AI to coordinate autonomous defense and security systems with real-time decision support.

VisionWave Holdings announced the development of Stratum AI, an agentic AI system designed to integrate autonomous platforms, sensors, and mission workflows for defense, homeland security, and commercial uses. Stratum AI aims to coordinate autonomous systems and fuse sensor data to provide real-time decision support, working alongside other AI technologies under development. These innovations seek to create a unified operational picture across multiple autonomous domains, although they are still in development and not yet commercially available or validated. The company emphasizes the potential of AI to enhance autonomous vehicle and sensor utility by connecting them through a common intelligence layer.

VisionWave's development of Stratum AI is the story's focus, with Pluang's Technology sector showing a breadth of 64 advancing and 76 declining stocks among 150 priced as of Oct 14, 2026, 16:01 WIB. Among notable movers, Appian Corp (APPN) rose 1.99% to USD 39.48 with a typical hold time of 21 days, Atomera Incorporated (ATOM) gained 1.84% to USD 3.87 with 100% buy order activity and a 16-day hold, while Seagate Technology Holdings PLC (STX) declined 1.58% to USD 735.03 with balanced buy/sell orders and a 41-day hold time.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App